These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8013096)
1. A simple enzyme-linked immunosorbent assay of human osteocalcin. Rosenquist C; Bonde M; Fledelius C; Qvist P Clin Chem; 1994 Jul; 40(7 Pt 1):1258-64. PubMed ID: 8013096 [TBL] [Abstract][Full Text] [Related]
2. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Rosenquist C; Qvist P; Bjarnason N; Christiansen C Clin Chem; 1995 Oct; 41(10):1439-45. PubMed ID: 7586514 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224 [TBL] [Abstract][Full Text] [Related]
4. Sandwich enzyme immunoassay of osteocalcin in serum with use of an antibody against human osteocalcin. Monaghan DA; Power MJ; Fottrell PF Clin Chem; 1993 Jun; 39(6):942-7. PubMed ID: 8504561 [TBL] [Abstract][Full Text] [Related]
5. [Effects of sex hormones on serum levels of nitric oxide and plasma angiotensin II in postmenopausal women]. Zheng X; He FF; Nie M; Sun ML; Ge QS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):635-8. PubMed ID: 12905695 [TBL] [Abstract][Full Text] [Related]
6. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302 [TBL] [Abstract][Full Text] [Related]
7. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809 [TBL] [Abstract][Full Text] [Related]
8. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study. Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321 [TBL] [Abstract][Full Text] [Related]
9. Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium. Byrjalsen I; Thormann L; Meinecke B; Riis BJ; Christiansen C Obstet Gynecol; 1992 Apr; 79(4):523-8. PubMed ID: 1532445 [TBL] [Abstract][Full Text] [Related]
10. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794 [TBL] [Abstract][Full Text] [Related]
11. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy. Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668 [TBL] [Abstract][Full Text] [Related]
12. Homologous radioimmunoassay of human osteocalcin. Bouillon R; Vanderschueren D; Van Herck E; Nielsen HK; Bex M; Heyns W; Van Baelen H Clin Chem; 1992 Oct; 38(10):2055-60. PubMed ID: 1394989 [TBL] [Abstract][Full Text] [Related]
13. Avidin-biotin enzyme immunoassay of osteocalcin in serum or plasma. Jaouhari J; Schiele F; Dragacci S; Tarallo P; Siest JP; Henny J; Siest G Clin Chem; 1992 Oct; 38(10):1968-74. PubMed ID: 1394980 [TBL] [Abstract][Full Text] [Related]
14. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. Chen JT; Hosoda K; Hasumi K; Ogata E; Shiraki M J Bone Miner Res; 1996 Nov; 11(11):1784-92. PubMed ID: 8915787 [TBL] [Abstract][Full Text] [Related]
15. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women. Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581 [TBL] [Abstract][Full Text] [Related]
16. Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days. Yasui T; Uemura H; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M Menopause; 2006; 13(2):314-22. PubMed ID: 16645545 [TBL] [Abstract][Full Text] [Related]
17. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives. Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the contribution of dydrogesterone to bone turnover changes in postmenopausal women commencing hormone replacement therapy. Tobias JH; Clarke S; Mitchell K; Robins S; Amer H; Fraser WD J Clin Endocrinol Metab; 2001 Mar; 86(3):1194-8. PubMed ID: 11238508 [TBL] [Abstract][Full Text] [Related]
19. Determination of bone Gla protein (osteocalcin) by enzyme-linked immunosorbent assay. Egsmose C; Daugaard H; Lund B Clin Chim Acta; 1989 Oct; 184(3):279-87. PubMed ID: 2612000 [TBL] [Abstract][Full Text] [Related]
20. Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption. Bonde M; Fledelius C; Qvist P; Christiansen C Clin Chem; 1996 Oct; 42(10):1639-44. PubMed ID: 8855148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]